Crispr Therapeutics Ag (CRSP) - News Archive

In an era where gene editing stands at the forefront of medical innovation, CRISPR Therapeutics AG has garnered attention for its recent revelations concerning CTX460, a revolutionary therapeutic candidate designed to c...

In a promising development for the field of gene-based therapies, CRISPR Therapeutics and Sirius Therapeutics have announced the initiation of a Phase 2 clinical trial for SRSD107, marking the dosing of the first patien...

CRISPR Therapeutics, a leading biopharmaceutical company dedicated to pioneering gene-based treatments for severe health conditions, is set to make significant waves at the upcoming American Heart Association (AHA) Scie...

Overview of Recent DevelopmentsCRISPR Therapeutics, a trailblazer in the realm of gene editing technologies, has recently made noteworthy progress in the treatment of severe genetic disorders, specifically sickle cell d...

CRISPR Therapeutics, a leading biopharmaceutical company at the forefront of gene editing technology, has made significant strides recently in the treatment of serious genetic disorders such as sickle cell disease (SCD)...

Gene editing technologies like CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) have revolutionized the field of medicine by offering potential cures for previously incurable diseases. CRISPR Therapeut...

In a game-changing move for Crispr Therapeutics Ag, new investor EcoR1 Capital and SR One have led a significant round of funding with participation from existing and new investors. This strategic investment is set to h...

For the first time, a revolutionary gene-editing therapy called CASGEVY (exagamglogene autotemcel) has been authorized by the European Commission for the treatment of both Sickle Cell Disease (SCD) and Transfusion-Depen...

The field of gene editing and therapeutic techniques has recently witnessed a monumental stride as the FDA (U.S. Food and Drug Administration) sanctions a pioneer gene-editing treatment for Transfusion-Dependent Beta Th...

CRISPR Therapeutics: Pioneering the Future of Immuno-Oncology and Autoimmune Disease TreatmentIn a groundbreaking announcement, CRISPR Therapeutics, a leading gene-editing company, unveiled updates to their immuno-oncol...